Clinical Trial Update: Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study

View source ↗

Summary

The OZURDEX AUSSIEDEX trial evaluating the dexamethasone intravitreal implant (OZURDEX) for diabetic macular edema in Australia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Diabetic Macular Oedema | Status: COMPLETED